Atria Wealth Solutions’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-6,825
Closed -$213K – 1807
2025
Q1
$213K Buy
+6,825
New +$223K ﹤0.01% 1680
2024
Q3
– Sell
-10,119
Closed -$314K – 2028
2024
Q2
$314K Buy
10,119
+93
+0.9% +$2.77K ﹤0.01% 1474
2024
Q1
$298K Buy
+10,026
New +$284K ﹤0.01% 1561

Other funds holding QLTY

Atria Wealth Solutions's QLTY Position: Q2 2025 in Review

Atria Wealth Solutions sold out of GMO US Quality ETF (QLTY) in Q2 2025, closing a stake of 6,825 shares — an estimated $213K sold.

Atria Wealth Solutions first reported a position in QLTY in Q1 2024 and held it in 3 quarters. The position peaked at $314K in Q2 2024. 111 funds tracked by Wall St. Rank hold QLTY as of Q2 2025.

  • Atria Wealth Solutions reported no remaining GMO US Quality ETF position as of Q2 2025 after selling out during the quarter.
  • Atria Wealth Solutions sold 6,825 GMO US Quality ETF shares in Q2 2025, an estimated $213K.
  • Atria Wealth Solutions first reported a position in GMO US Quality ETF in Q1 2024 and held it in 3 quarters.
  • Atria Wealth Solutions's GMO US Quality ETF position peaked at $314K in Q2 2024.
  • 111 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.